Skip to main content

Table 2 Frequencies of KIR haplotypes and HLA alleles among individuals acute ischemic stroke and in subjects without stroke

From: HLA and killer cell immunoglobulin-like receptor (KIRs) genotyping in patients with acute ischemic stroke

Aplotipo KIR Subjects with acute ischemic stroke (n 116) Subjects without acute ischemic stroke (n 66) p
2DL1 (n/%) 64 (55.17) 43 (65.16) 0.21
2DL2 (n/%) 41 (35.34) 26 (39.3) 0.63
2DL3 (n/%) 86 (74.1) 28 (42.4) < 0.0001
2DL4 (n/%) 84 (72.4) 66 (100) < 0.0001
2DL5A (n/%) 14 (12.06) 12 (18.8) 0.27
2DL5B (n/%) 39 (33.6) 12 (18.8) 0.03
2DS1 (n/%) 24 (20.6) 18 (27.2) 0.36
2DS2 (n/%) 44 (37.9) 11 (16.6) 0.003
2DS3 (n/%) 31 (26.7) 17 (25.7) 1
2DS4 (n/%) 48 (41.3) 11 (16.6) 0.001
2DS5 (n/%) 17 (14.6) 34 (51.5) < 0.0001
3DL1 (n/%) 78 (67.2) 59 (89.3) 0.001
3DL2 (n/%) 78 (67.2) 66 (100) < 0.0001
3DL3 (n/%) 73 (62.9) 66 (100) < 0.0001
3DS1 (n/%) 60 (51.7) 37 (56.06) 0.64
2DP1 (n/%) 90 (77.5) 66 (100) < 0.0001
3DP1 (n/%) 17 (14.6) 0 < 0.0001
3DP1*003 (n/%) 73 (62.9) 66 (100) < 0.0001
KIR-aplotypes    
HLA-A (n/%) 52 (44.8) 30 (45.4) 1.0
HLA-A+B (n/%) 62 (53.4) 37 (56.0) 0.76
HLA alleles    
HLA-Bw4 T (n/%) 31 (26.7) 13 (19.6) 0.36
HLA-A-BW4 (n/%) 31 (26.7) 16 (24.2) 0.85
HLA-B-Bw4I (n/%) 10 (8.6) 43 (65.1) < 0.0001
HLA-C1 (n/%) 38 (32.7) 26 (39.3) 0.420
HLA-C2 (n/%) 36 (31.03) 19 (28.7) 0.86
  1. KIR killer cell immunoglobulin-like receptor, HLA human leukocyte antigen